$7.96
-0.44-5.24%
最終更新: Oct 27, 4:00 PM
Benzinga
Benzinga
Benzinga
木曜日, 10 29
Benzinga
© 2026 Benzinga | All Rights Reserved
AgomAb Therapeutics (AGMB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| FY | Apr 23, 2026 | $-166.72 | $-1.79 | -9214.0 % |
Quarterly Revenue (Billions)
| Metric | H1 '26 | FY '25 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | — | $-1.79 |
| Actual | $-0.93 | $-166.72 |
| Surprise | — | -9214.0% |
| Revenue | ||
| Estimate | — | — |
| Actual | $0 | $0 |
| Surprise | — | — |
| Metric | Q3 '26E | Q4 '26E | FY '26E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.32 | $-0.41 | $-1.77 |
| Revenue | |||
| Consensus | — | — | — |